These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8213065)

  • 21. [Anti-GFAP antibodies in the cerebrospinal fluid of patients with multiple sclerosis and other neurologic diseases].
    Górny M; Losy J; Wender M
    Neurol Neurochir Pol; 1990; 24(1-2):17-22. PubMed ID: 2132049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific monoclonal antibodies to glial fibrillary acidic protein (GFAP).
    Courel MN; Girard N; Delpech B; Chauzy C
    J Neuroimmunol; 1986 Jun; 11(4):271-6. PubMed ID: 3711313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic motor evoked potentials (MEP) in diseases of the spinal cord.
    Linden D; Berlit P
    Acta Neurol Scand; 1994 Nov; 90(5):348-53. PubMed ID: 7887135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-goldfish glial fibrillary acidic protein (GFAP) recognises astrocytes from rat CNS.
    Shehab SS; Stafford CA; Nona SN; Cronly-Dillon JR
    Brain Res; 1989 Dec; 504(2):343-6. PubMed ID: 2598035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmune GFAP astrocytopathy after viral encephalitis: A case report.
    Li J; Xu Y; Ren H; Zhu Y; Peng B; Cui L
    Mult Scler Relat Disord; 2018 Apr; 21():84-87. PubMed ID: 29499442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants.
    Blauth K; Soltys J; Matschulat A; Reiter CR; Ritchie A; Baird NL; Bennett JL; Owens GP
    Acta Neuropathol; 2015 Dec; 130(6):765-81. PubMed ID: 26511623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multilevel somatosensory evoked potentials and cerebrospinal proteins: indicators of spinal cord injury in thoracoabdominal aortic aneurysm surgery.
    Winnerkvist A; Anderson RE; Hansson LO; Rosengren L; Estrera AE; Huynh TT; Porat EE; Safi HJ
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):637-42. PubMed ID: 17306553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme-linked immunosorbent assay for the human glial fibrillary acidic protein using a mouse monoclonal antibody.
    Albrechtsen M; Massaro A; Bock E
    J Neurochem; 1985 Feb; 44(2):560-6. PubMed ID: 3880805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diversity among reactive astrocytes: proximal reactive astrocytes in lacerated spinal cord preferentially react with monoclonal antibody J1-31.
    Malhotra SK; Svensson M; Aldskogius H; Bhatnagar R; Das GD; Shnitka TK
    Brain Res Bull; 1993; 30(3-4):395-404. PubMed ID: 8457889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Affinity immunoblotting: rapid and sensitive detection of oligoclonal IgG, IgA and IgM in unconcentrated CSF by agarose isoelectric focusing.
    Kaiser R
    J Neurol Sci; 1991 Jun; 103(2):216-25. PubMed ID: 1880540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune GFAP astrocytopathy presenting with remarkable CNS hyperexcitability and oculogyric crises.
    Equiza J; Rodríguez-Antigüedad J; Campo-Caballero D; Iruzubieta P; Prada Á; Roncancio A; Fernández E; Ganzarain Oyarbide M; Arruti M; Urtasun MA; Castillo-Triviño T
    J Neuroimmunol; 2021 Oct; 359():577695. PubMed ID: 34416409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An immunocytochemical study of normal and abnormal human cerebrospinal fluid with monoclonal antibodies to glial fibrillary acidic protein.
    Trojanowski JQ; Atkinson B; Lee VM
    Acta Cytol; 1986; 30(3):235-9. PubMed ID: 3459324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients with suspected benign tumors and glial fibrillary acidic protein autoantibody: an analysis of five cases.
    Huang Q; Yang H; Liu T; Xu H; Chen B; Liu S; Li W; Long Y; Gao C
    Int J Neurosci; 2019 Dec; 129(12):1183-1188. PubMed ID: 31327295
    [No Abstract]   [Full Text] [Related]  

  • 34. Monoclonal antibodies reactive with epitopes restricted to glial fibrillary acidic proteins of several species.
    Pegram CN; Eng LF; Wikstrand CJ; McComb RD; Lee YL; Bigner DD
    Neurochem Pathol; 1985; 3(2):119-38. PubMed ID: 2413405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple sclerosis and intrathecal IgA synthesis.
    Sena A; Rosado P; Ferret-Sena V; Coimbra J; Schuller E; Sindic CJ
    Acta Neurol Belg; 1997 Mar; 97(1):36-8. PubMed ID: 9107343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dermatomal somatosensory evoked potentials in the diagnosis of focal lesions of the spinal cord].
    Prieto J; Esteban A
    Neurologia; 1995 Nov; 10(9):355-61. PubMed ID: 8554790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral calcification in a patient with systemic lupus erythematosus and a monoclonal IgG reactive with glial fibrillary acidic protein.
    Stuart BM; Gregson NA
    Br J Rheumatol; 1998 Dec; 37(12):1355-7. PubMed ID: 9973167
    [No Abstract]   [Full Text] [Related]  

  • 38. A neurofilament polypeptide and the glial fibrillary acidic protein share common epitopes in the variable region.
    Krauss RY; Alvarez J; Inestrosa NC
    Neurosci Lett; 1993 Oct; 161(2):137-40. PubMed ID: 7505907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, immunological and MRI features of myelitis with atopic dermatitis (atopic myelitis).
    Kira J; Kawano Y; Horiuchi I; Yamada T; Imayama S; Furue M; Yamasaki K
    J Neurol Sci; 1999 Jan; 162(1):56-61. PubMed ID: 10064169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spinal somatosensory evoked potentials: maturational and clinical studies.
    Cracco JB; Cracco RQ
    Ann N Y Acad Sci; 1982; 388():526-37. PubMed ID: 6953886
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.